Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

New brain cancer guidelines to improve care, patient survival

New brain cancer guidelines to improve care, patient survival

Nanoparticle-formulated drug combination is effective in medulloblastoma, a paediatric brain tumour

Nanoparticle-formulated drug combination is effective in medulloblastoma, a paediatric brain tumour

Stem cell discoveries hold potential to improve cancer treatment

Stem cell discoveries hold potential to improve cancer treatment

Faulty BRCA genes linked to prostate and pancreatic cancers

Faulty BRCA genes linked to prostate and pancreatic cancers

Death rates from ovarian cancer will fall in the EU and UK in 2022

Death rates from ovarian cancer will fall in the EU and UK in 2022

New discovery shows how targeting healthy cells could help develop treatments for pancreatic cancer

New discovery shows how targeting healthy cells could help develop treatments for pancreatic cancer

ASCO GI 2022: Ripretinib demonstrates comparable efficacy and fewer side effects compared to sunitinib in patients with GIST previously treated with imatinib

ASCO GI 2022: Ripretinib demonstrates comparable efficacy and fewer side effects compared to sunitinib in patients...

Young-onset cancers in Australia rise, and experts don't know why

Young-onset cancers in Australia rise, and experts don't know why

ASCO GI 2022: Durvalumab plus tremelimumab significantly improves survival for patients with advanced liver cancer compared to sorafenib

ASCO GI 2022: Durvalumab plus tremelimumab significantly improves survival for patients with advanced liver cancer...

ASCO GI 2022: Durvalumab significantly improves survival for patients with biliary tract cancer compared to chemotherapy alone

ASCO GI 2022: Durvalumab significantly improves survival for patients with biliary tract cancer compared to...

More from ecancer